This combination therapy is expected to achieve a 15% reduction in body weight after 32 weeks, offering a significant improvement over existing treatments
It is expansion of the entire GLP-1 market Access vs readiness gap Affordability is improving faster than systems for awareness, adherence, and monitoring Execution will define winners Beyond pricing, success will depend on physician trust, patient journeys, and real-world outcomes Shift in pharma playbook From innovation-led launches to access-led scaling strategies This is one of the rare moments where generics dont just erode value
And for those unhappy with a double chin, liposuction can be used to contour the jawline
These medications are vastly different, despite being in the same medication class, agrees Jodie Pepin, Pharm.D., clinical pharmacy program manager at Harbor Health in Round Rock, Texas